CAS RN: 2216-33-3
3-Methyloctane
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
99%(GC) (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250128
1ml
In stock
Shanghai, Shandong Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5ml
Available purity: ≥99%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2216-33-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5ml
≥99%
0
Out of Stock
Shanghai
Inquiry
2216-33-3 / 3-methyloctane
Standard CAS: 2216-33-3
Multi CAS: No
Basic Information
copy
CAS
2216-33-3 copy
Multi CAS
No copy
Molecular Formula
C9H20 copy
Molecular Weight
128.250000 copy
Exact Mass
128.156501 copy
SMILES
CCCCCC(C)CC copy
InChI
InChI=1S/C9H20/c1-4-6-7-8-9(3)5-2/h9H,4-8H2,1-3H3 copy
InChIKey
SEEOMASXHIJCDV-UHFFFAOYSA-N copy
Physical Properties
copy
Physical Description
Clear colorless liquid copy
State
Liquid copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
1 copy
Rotatable bonds
5 copy
Molar refractivity
43.6 copy
TPSA
0.0000 copy
LogP / Solubility
WLOGP
3.61 copy
MLOGP
3.17 copy
XLogP3
4.8 copy
Consensus LogP
3.86 copy
Log S (ESOL)
-2.58 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.22 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-4.09 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-0.94 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy